Literature DB >> 11318876

Down-regulation of alpha6 integrin, an anti-oncogene product, by functional cooperation of H-Ras and c-Myc.

H Fujimoto1, Y Tanaka, Z J Liu, H Yagita, K Okumura, A Kosugi, A Morinobu, H Umehara, H Yamamura, Y Minami.   

Abstract

BACKGROUND: The molecular basis of cooperation of H-Ras and c-Myc in regulating cellular behaviour, such as cell adhesiveness, is still poorly understood. To investigate the role of H-Ras and c-Myc in cell adhesiveness, a constitutively active H-RasV12 (H-RasV12) and c-Myc were stably expressed, singly or in combination in a haematopoietic cell line, and the expression and activity of cell adhesion molecules were monitored.
RESULTS: We have shown that the ectopic expression of H-RasV12, but not c-Myc alone, in a haematopoietic cell line, induces the activation of very late antigen-6 (VLA-6, alpha6beta1) integrin. Co-expression of H-RasV12 and c-Myc in the same cells further resulted in the induction of expression of vascular cell adhesion molecule-1 (VCAM-1) and the inhibition of expression of alpha6 integrin, a candidate anti-oncogene product, leading to a loss of adhesiveness to laminin (Lm), a ligand for VLA-6.
CONCLUSIONS: Cooperation of H-Ras and c-Myc reciprocally regulates expression of the adhesion molecules, alpha6 integrin and VCAM-1. Our results represent an unprecedented account of the cooperation of the oncogene products, H-Ras and c-Myc, to inhibit expression of an anti-oncogene product, alpha6 integrin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11318876     DOI: 10.1046/j.1365-2443.2001.00428.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  3 in total

1.  Integrin α1β1 expression is controlled by c-MYC in colorectal cancer cells.

Authors:  S Boudjadi; J C Carrier; J-F Groulx; J-F Beaulieu
Journal:  Oncogene       Date:  2015-06-22       Impact factor: 9.867

2.  Preclinical Evaluation of a Novel Dual Targeting PI3Kδ/BRD4 Inhibitor, SF2535, in B-Cell Acute Lymphoblastic Leukemia.

Authors:  Yongsheng Ruan; Hye Na Kim; Heather A Ogana; Zesheng Wan; Samantha Hurwitz; Cydney Nichols; Nour Abdel-Azim; Ariana Coba; Seyoung Seo; Yong-Hwee Eddie Loh; Eun Ji Gang; Hisham Abdel-Azim; Chih-Lin Hsieh; Michael R Lieber; Chintan Parekh; Dhananjaya Pal; Deepa Bhojwani; Donald L Durden; Yong-Mi Kim
Journal:  Front Oncol       Date:  2021-12-01       Impact factor: 6.244

3.  CX3CR1 receptor polymorphisms, Th1 cell recruitment, and acute myocardial infarction outcome: looking for a link.

Authors:  S Pucci; P Mazzarelli; M J Zonetti; T Fisco; E Bonanno; L G Spagnoli; A Mauriello
Journal:  Biomed Res Int       Date:  2013-11-07       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.